Drugs / CMAB807X
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05808673 | Feb 2023 → Jun 2024 | — | Taizhou Mabtech Pharmaceutical Co.,Ltd | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMAB807X | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05808673 ↗ |